Education
About Us
Working with TipRanks
Follow Us
Global Cord Blood (CORBF)
OTHER OTC:CORBF
Total Valuation
Global Cord Blood has a market cap or net worth of $100.44M. The enterprise value is ―.
Market Cap$100.44M
Enterprise Value―
Share Statistics
Global Cord Blood has 133,914,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding133,914,720
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Global Cord Blood’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.03M
Profits Per Employee423.86K
Employee Count1,202
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Global Cord Blood is ―. Global Cord Blood’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow1.06
PEG Ratio0.00
Income Statement
In the last 12 months, Global Cord Blood had revenue of 1.24B and earned 501.06M in profits. Earnings per share was 4.12.
Revenue1.24B
Gross Profit1.06B
Operating Income608.87M
Pretax Income627.84M
Net Income501.06M
EBITDA656.79M
Earnings Per Share (EPS)4.12
Cash Flow
In the last 12 months, operating cash flow was 161.70M and capital expenditures 0.00, giving a free cash flow of 161.70M billion.
Operating Cash Flow161.70M
Free Cash Flow161.70M
Free Cash Flow per Share1.21
Dividends & Yields
Global Cord Blood pays an annual dividend of $0.08, resulting in a dividend yield of ―
Dividend Per Share$0.08
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.72
52-Week Price Change-28.57%
50-Day Moving Average0.83
200-Day Moving Average0.95
Relative Strength Index (RSI)42.98
Average Volume (3m)1.14K
Important Dates
Global Cord Blood upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Global Cord Blood as a current ratio of ―, with Debt / Equity ratio of <0.01%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Global Cord Blood has paid 118.35M in taxes.
Income Tax118.35M
Effective Tax Rate―
Enterprise Valuation
Global Cord Blood EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Global Cord Blood has $1.05B in cash and marketable securities with $23.00K in debt, giving a net cash position of $1.05B billion.
Cash & Marketable Securities$1.05B
Total Debt$23.00K
Net Cash$1.05B
Net Cash Per Share$7.85
Tangible Book Value Per Share―
Margins
Gross margin is 85.26%, with operating margin of ―, and net profit margin of ―.
Gross Margin85.26%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Global Cord Blood is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―